RxDoctor Payments Data

Khaled Shukairy, MD

Otolaryngology/Facial Plastic Surgery · Burton, MINPI 1518961879

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 36.1% of the total. 2025 is the largest year on record at $501, 2.6 times the $195 reported in 2019.

$2,335in general payments, 2019–2025

Across 107 payments — averaging $21.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$842
  • Sanofi$580
  • GSK$314
  • Optinose US, Inc.$92
  • Amgen$76
  • Inspire Medical Systems, Inc.$53
  • plus $377 from 13 others

What the payments were for

  • Food & beverage$2,335100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,335 in reported general payments places this provider in the 55th percentile of 31 otolaryngology/facial plastic surgery providers in Michigan.

See all otolaryngology/facial plastic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$128,324
Medicare patients
413
Services billed
2,648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab23$85,579
Montelukast Sodium1,054$7,585
Cephalexin355$2,731
Levocetirizine Dihydrochloride236$2,381
Ofloxacin60$2,017
Fluticasone Propionate168$1,993
Omeprazole217$1,455
Pantoprazole Sodium41$1,011
Famotidine215$880
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav74$853
Azithromycin209$785
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen106$775
Ibuprofen76$389
Doxycycline Hyclate56$383
Prednisone109$298

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Burton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →